Katia J Bruxvoort Selected Research

Vaccines

12/2024	Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
12/2023	Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5.
10/2023	Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study.
1/2023	mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States.
1/2023	Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine.
1/2023	Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study.
1/2023	Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study.
1/2023	Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults.
1/2023	Prevention of Neisseria gonorrhoeae With Meningococcal B Vaccine: A Matched Cohort Study in Southern California.
3/2022	Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katia J Bruxvoort Research Topics

Disease

13	COVID-19 12/2024 - 12/2021
10	Infections 12/2024 - 01/2019
4	Malaria 01/2020 - 03/2017
3	Herpes Zoster 01/2023 - 01/2019
2	Respiratory Tract Infections (Respiratory Tract Infection) 11/2023 - 01/2022
1	Frailty 04/2024
1	Breakthrough Infections 10/2023
1	Urinary Tract Infections (Urinary Tract Infection) 08/2023
1	Gonorrhea 01/2023
1	Rheumatoid Arthritis 01/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	Pneumonia (Pneumonitis) 01/2022
1	Hepatitis D 12/2021
1	Human Influenza (Influenza) 01/2019
1	Pain (Aches) 01/2019
1	Fever (Fevers) 10/2017
1	Carcinoma (Carcinomatosis) 03/2007
1	Carcinogenesis 03/2007
1	Prostatic Neoplasms (Prostate Cancer) 03/2007
1	Neoplasms (Cancer) 03/2007

Drug/Important Bio-Agent (IBA)

17	VaccinesIBA 12/2024 - 01/2019
10	2019-nCoV Vaccine mRNA-1273IBA 12/2024 - 12/2021
4	COVID-19 VaccinesIBA 12/2024 - 01/2023
4	Conjugate VaccinesIBA 11/2023 - 01/2022
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 03/2017
3	Herpes Zoster VaccineIBA 03/2022 - 01/2019
3	Antimalarials (Antimalarial Agents)IBA 01/2020 - 03/2017
2	Combined VaccinesIBA 12/2024 - 01/2023
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 12/2023 - 10/2023
2	N-(2-cyanoethylene)urea (BA 1)IBA 12/2023 - 10/2023
2	Messenger RNA (mRNA)IBA 10/2023 - 01/2023
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 08/2023 - 03/2017
2	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2022 - 01/2022
2	artemisinin (artemisinine)IBA 01/2020 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2007
1	Third Generation CephalosporinsIBA 08/2023
1	Nitrofurantoin (Macrodantin)FDA LinkGeneric 08/2023
1	FluoroquinolonesIBA 08/2023
1	aluminum sulfate (alum)IBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 01/2023
1	MenACWYIBA 01/2023
1	Polysaccharides (Glycans)IBA 01/2023
1	13-valent pneumococcal vaccineIBA 01/2022
1	23-valent pneumococcal capsular polysaccharide vaccineIBA 01/2022
1	Ribosomal DNA (rDNA)IBA 01/2019
1	Histidine (L-Histidine)FDA Link 01/2019
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2019
1	Penicillins (Penicillin)FDA Link 03/2017
1	Metronidazole (Metric)FDA LinkGeneric 03/2017
1	TetracyclinesIBA 03/2017
1	probasinIBA 03/2007
1	beta CateninIBA 03/2007
1	AndrogensIBA 03/2007

Therapy/Procedure

2	Ambulatory Care (Outpatient Care) 12/2024 - 01/2023
2	Therapeutics 01/2020 - 10/2017
1	Transplantation 04/2024
1	Inappropriate Prescribing 01/2020
1	Castration 03/2007